Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ) main shareholder Hengqin Dingdian and its concerted action party have completed the reduction of 757,400 shares.

15/01/2025

West Point Pharmaceutical Co., Ltd. (301130.SZ) announced that its shareholder, Hengqin Dingdian Equity Investment Fund Partnership, holds more than 5% of the company's shares.

Announcement of Jilin Province Xidian Pharmaceutical Sci-Tech Development (301130.SZ): Shareholders holding more than 5% of the company, Hengqin Dingdian Equity Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "Hengqin Dingdian") and its concerted action person Zhuhai Hengqin Runhuiyi Investment Partnership Enterprise (Limited Partnership) (formerly known as Hengqin Runhuiyi Equity Investment Fund Partnership Enterprise (Limited Partnership)) (referred to as "Zhuhai Hengqin Runhuiyi"), have collectively reduced their shares by 757,400 shares, accounting for 0.99% of the total share capital. The implementation of this reduction plan has been completed.

Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.

Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.

HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th

Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.

Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.

HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th